Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |